Drugs / CD117 CAR T-cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07144020 | Sep 2025 → Sep 2028 expected | acute myeloid leukemia | Zhejiang University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD117 CAR T-cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07144020 ↗ |
| Modality | Cell therapy | “CAR-T Cell” NCT07144020 ↗ |
| Route | Intravenous | “Each subject receive CD117 CAR T-cells by intravenous infusion” NCT07144020 ↗ |